Vertex Pharmaceuticals, Inc.

NASDAQ:VRTX  
188.36
+1.26 (+0.67%)
4:02:35 PM EDT: $188.11 -0.25 (-0.13%)
Products, Strategic Combinations

Vertex And Arbor Biotechnologies Establish New Partnership To Develop Novel Ex Vivo Engineered Cell Therapies

Published: 08/24/2021 14:22 GMT
Vertex Pharmaceuticals, Inc. (VRTX) - Vertex and Arbor Biotechnologies Establish New Partnership to Develop Novel Ex Vivo Engineered Cell Therapies.
Vertex Pharmaceuticals - Under Agreement, Arbor Will Receive an Upfront Cash Payment and is Eligible to Receive Up to $1.2 Billion in Potential Payments.
Vertex Pharmaceuticals Inc - Vertex Will Also Make an Investment in Arbor in Form of a Convertible Note.
Vertex Pharmaceuticals Inc - in Addition, Vertex Will Pay Tiered Royalties on Future Net Sales on Any Products That May Result From This Collaboration.